FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jean Bénard

Research Profile

Disorders

Genes & Molecular Sequences

Chemicals & Drugs

Anatomy

Living Beings

Physiology

Co-author Network

Publications

TOP 3
Nora Berois; Laura Capandeguy; Sétha Douc-Rasy; Charles-Henry Gattolliat; Enrique Barrios; Jean Bénard; Dominique Valteau-Couanet; Eduardo Osinaga
GALNT9 gene expression is a prognostic marker in neuroblastoma patients.
Mona Samy; Jean Bénard; Sophie Bombard; Sétha Douc-Rasy; Charles-Henry Gattolliat; Josette Hillion; Eric Nguyen; Frédéric Pendino; Evelyne Ségal-Bendirdjian
Loss of the malignant phenotype of human neuroblastoma cells by a catalytically inactive dominant-negative hTERT mutant.
Christophe Massard; Ludovic Lacroix; Nathalie Auger; Jean Bénard
[Chromosomal rearrangements and fusion genes in carcinoma].

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jean Bénard (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Nora Berois; Laura Capandeguy; Sétha Douc-Rasy; Charles-Henry Gattolliat; Enrique Barrios; Jean Bénard; Dominique Valteau-Couanet; Eduardo Osinaga
GALNT9 gene expression is a prognostic marker in neuroblastoma patients.
Clinical chemistry 2013;59(1):225-33.
2012: Mona Samy; Jean Bénard; Sophie Bombard; Sétha Douc-Rasy; Charles-Henry Gattolliat; Josette Hillion; Eric Nguyen; Frédéric Pendino; Evelyne Ségal-Bendirdjian
Loss of the malignant phenotype of human neuroblastoma cells by a catalytically inactive dominant-negative hTERT mutant.
Molecular cancer therapeutics 2012;11(11):2384-93.
2011: Christophe Massard; Ludovic Lacroix; Nathalie Auger; Jean Bénard
[Chromosomal rearrangements and fusion genes in carcinoma].
Bulletin du cancer 2011;98(12):1395-401.
2011: M Grynberg; Laetitia Hesters; Jean Bénard; R Trèves; Renato Fanchin; René Frydman; Frydman Nelly
[In vitro maturation of oocytes: an option for fertility preservation in women].
Journal de gynécologie, obstétrique et biologie de la reproduction 2011;40(2):103-8.
2011: Anne Chauchereau; Nader Al Nakouzi; Catherine Gaudin; Sylvestre Le Moulec; Daniel Compagno; Nathalie Auger; Jean Bénard; Paule Opolon; François Rozet; Pierre Validire; Gaëlle Fromont; Karim Fizazi
Stemness markers characterize IGR-CaP1, a new cell line derived from primary epithelial prostate cancer.
Experimental cell research 2011;317(3):262-75.
2010: Julien Dômont; S Salas; ludovic lacroix; V Brouste; P Saulnier; Philippe Terrier; Dominique Ranchère; A Neuville; A Leroux; Louis Guillou; Raf Sciot; Françoise Collin; A Dufresne; Jean-Yves Blay; Axel Le Cesne; Jean-Michel Coindre; S Bonvalot; Jean Bénard
High frequency of beta-catenin heterozygous mutations in extra-abdominal fibromatosis: a potential molecular tool for disease management.
British journal of cancer 2010;102(6):1032-6.
2010: Xénia Mergui; Marie-Line Puiffe; Dominique Valteau-Couanet; Marc Lipinski; Jean Bénard; Mounira Amor-Guéret
p21Waf1 expression is regulated by nuclear intermediate filament vimentin in neuroblastoma.
BMC cancer 2010;10():473.
2009: Céline Delloye-Bourgeois; Julien Fitamant; Andrea Paradisi; David Cappellen; Sétha Douc-Rasy; Marie-Anne Raquin; Stupack Dwayne; Akira Nakagawara; Raphaël Rousseau; Valérie Combaret; Alain Puisieux; Dominique Valteau-Couanet; Jean Bénard; Agnès Bernet; Patrick Mehlen
Netrin-1 acts as a survival factor for aggressive neuroblastoma.
The Journal of experimental medicine 2009;206(4):833-47.
2009: Gilda Raguénez; Annick Mühlethaler-Mottet; Roland Meier; Caroline Duros; Jean Bénard; Nicole Gross
Fenretinide-induced caspase-8 activation and apoptosis in an established model of metastatic neuroblastoma.
BMC cancer 2009;9():97.
2008: Jean Bénard; Gilda Raguénez; Audrey Kauffmann; Alexander Valent; Hugues Ripoche; Virginie Joulin; Bastien Job; Gisèle Danglot; Sabrina Cantais; Thomas Robert; Marie-José Terrier-Lacombe; Agnès Chassevent; Serge Koscielny; Matthias Fischer; Frank Berthold; Marc Lipinski; Thomas Tursz; Philippe Dessen; Vladimir Lazar; Dominique Valteau-Couanet
MYCN-non-amplified metastatic neuroblastoma with good prognosis and spontaneous regression: a molecular portrait of stage 4S.
Molecular oncology 2008;2(3):261-71.
2008: Daniel Satgé; Jean Bénard
Carcinogenesis in Down syndrome: what can be learned from trisomy 21?
Seminars in cancer biology 2008;18(5):365-71.
2008: Emilie Horvilleur; Matthieu Bauer; David Goldschneider; Xénia Mergui; Alix de la Motte; Jean Bénard; Sétha Douc-Rasy; David Cappellen
p73alpha isoforms drive opposite transcriptional and post-transcriptional regulation of MYCN expression in neuroblastoma cells.
Nucleic acids research 2008;36(13):4222-32.
2008: Laetitia Faridoni-Laurens; Sophie Tourpin; Samar Alsafadi; Michel Barrois; Stéphane Temam; François Janot; serge koscielny; Jacques Bosq; Jean Bénard; Jean-Charles Ahomadegbe
Involvement of N-terminally truncated variants of p73, deltaTAp73, in head and neck squamous cell cancer: a comparison with p53 mutations.
Cell cycle (Georgetown, Tex.) 2008;7(11):1587-96.
2006: Nora Berois; Etienne Blanc; Hugues Ripoche; Xénia Mergui; Felipe Trajtenberg; Sabrina Cantais; Michel Barrois; Philippe Dessen; Bertil Kågedal; Jean Bénard; Eduardo Osinaga; Gilda Raguénez
ppGalNAc-T13: a new molecular marker of bone marrow involvement in neuroblastoma.
Clinical chemistry 2006;52(9):1701-12.
2006: Karine Million; Emilie Horvilleur; David Goldschneider; Malik Agina; Gilda Raguénez; Frédéric Tournier; Jean Bénard; Sétha Douc-Rasy
Differential regulation of p73 variants in response to cisplatin treatment in SH-SY5Y neuroblastoma cells.
International journal of oncology 2006;29(1):147-54.
2006: David Goldschneider; Emilie Horvilleur; Louis-François Plassa; Marine Guillaud-Bataille; Karine Million; Evelyne Wittmer-Dupret; Gisèle Danglot; Hugues de Thé; Jean Bénard; Evelyne May; Sétha Douc-Rasy
Expression of C-terminal deleted p53 isoforms in neuroblastoma.
Nucleic acids research 2006;34(19):5603-12.
2005: Etienne Blanc; David Goldschneider; Sétha Douc-Rasy; Jean Bénard; Gilda Raguénez
Wnt-5a gene expression in malignant human neuroblasts.
Cancer letters 2005;228(1-2):117-23.
2005: Muriel Vayssade; Hedi Haddada; Laetitia Faridoni-Laurens; Sophie Tourpin; Alexander Valent; Jean Bénard; Jean-Charles Ahomadegbe
P73 functionally replaces p53 in Adriamycin-treated, p53-deficient breast cancer cells.
International journal of cancer. Journal international du cancer 2005;116(6):860-9.
2005: Jean Bénard; Sétha Douc-Rasy
[Micro-RNA and oncogenesis].
Bulletin du cancer 2005;92(9):757-62.
2005: Stéphane Temam; Jean Bénard; Christelle Dugas; Martine Trassard; Emmanuelle Gormally; Jean-Charles Soria; Sandrine Faivre; Bernard Luboinski; Patrick Marandas; Pierre Hainaut; Gilbert Lenoir; Li Mao; François Janot
Molecular detection of early-stage laryngopharyngeal squamous cell carcinomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(7):2547-51.
2005: David Goldschneider; Karine Million; Anne Meiller; Hedi Haddada; Alain Puisieux; Jean Bénard; Evelyne May; Sétha Douc-Rasy
The neurogene BTG2TIS21/PC3 is transactivated by DeltaNp73alpha via p53 specifically in neuroblastoma cells.
Journal of cell science 2005;118(Pt 6):1245-53.
2005: Etienne Blanc; Gwenaëlle Le Roux; Jean Bénard; Gilda Raguénez
Low expression of Wnt-5a gene is associated with high-risk neuroblastoma.
Oncogene 2005;24(7):1277-83.
2005: Jean Bénard; Nadine Béron-Gaillard; Daniel Satgé
Down's syndrome protects against breast cancer: is a constitutional cell microenvironment the key?
International journal of cancer. Journal international du cancer 2005;113(1):168-70.
2004: Loreley Calvet; Alexandre Santos; Alexander Valent; Marie-José Terrier-Lacombe; Paule Opolon; Jean-Louis Merlin; Geneviève Aubert; Jackie Morizet; J H M Schellens; Jean Bénard; Gilles Vassal
No topoisomerase I alteration in a neuroblastoma model with in vivo acquired resistance to irinotecan.
British journal of cancer 2004;91(6):1205-12.
2004: Anne Laprie; Jean Michon; Olivier Hartmann; Caroline Munzer; Marc-David Leclair; Carole Coze; Dominique Valteau-Couanet; Dominique Plantaz; Christian Carrie; Jean-Louis Habrand; Christophe Bergeron; Pascal Chastagner; Anne-Sophie Défachelles; Olivier Delattre; Valérie Combaret; Jean Bénard; Yves Pérel; Virginie Gandemer; Hervé Rubie
High-dose chemotherapy followed by locoregional irradiation improves the outcome of patients with international neuroblastoma staging system Stage II and III neuroblastoma with MYCN amplification.
Cancer 2004;101(5):1081-9.
2004: Alexander Valent; Marine Guillaud-Bataille; Chantal Farra; François Lozach; Barbara Spengler; Marie-José Terrier-Lacombe; Dominique Valteau-Couanet; Gisèle Danglot; Gilbert M Lenoir; Olivier Brison; Jean Bénard; Alain BERNHEIM
Alternative pathways of MYCN gene copy number increase in primary neuroblastoma tumors.
Cancer genetics and cytogenetics 2004;153(1):10-5.
2004: Alexandre Santos; Loreley Calvet; Marie-José Terrier-Lacombe; Annette Larsen; Jean Bénard; Corinne Pondarré; Geneviève Aubert; Jackie Morizet; François Lavelle; Gilles Vassal
In vivo treatment with CPT-11 leads to differentiation of neuroblastoma xenografts and topoisomerase I alterations.
Cancer research 2004;64(9):3223-9.
2004: Sétha Douc-Rasy; David Goldschneider; Karine Million; Jean Bénard
[Interrelations between p73 and p53: a model, neuroblastoma].
Médecine sciences : M/S 2004;20(3):317-24.
2004: Gilda Raguénez; Etienne Blanc; Jean Bénard
[Metastatic potential: a generic characteristic of the primary tumor].
Bulletin du cancer 2004;91(2):129-32.
2004: David Goldschneider; Etienne Blanc; Gilda Raguénez; Michel Barrois; Agnès Legrand; Gwenaëlle Le Roux; Hedi Haddada; Jean Bénard; Sétha Douc-Rasy
Differential response of p53 target genes to p73 overexpression in SH-SY5Y neuroblastoma cell line.
Journal of cell science 2004;117(Pt 2):293-301.
2004: Marine Guillaud-Bataille; Alexander Valent; Pascal Soularue; Christine Perot; María Mar Inda; Aline Receveur; Sadek Smaïli; Hugues Roest Crollius; Jean Bénard; Alain BERNHEIM; Xavier Gidrol; Gisèle Danglot
Detecting single DNA copy number variations in complex genomes using one nanogram of starting DNA and BAC-array CGH.
Nucleic acids research 2004;32(13):e112.
2003: Daniel Satgé; Samuel W Moore; Charles A Stiller; Félix K Niggli; Kathy Pritchard-Jones; Nick Bown; Jean Bénard; Dominique Plantaz
Abnormal constitutional karyotypes in patients with neuroblastoma: a report of four new cases and review of 47 others in the literature.
Cancer genetics and cytogenetics 2003;147(2):89-98.
2003: Gilda Raguénez; Jean Bénard
[Predicting metastatic potential: genetic markers].
Médecine sciences : M/S 2003;19(11):1050-1.
2003: David Goldschneider; Etienne Blanc; Gilda Raguenez; Hedi Haddada; Jean Bénard; Sétha Douc-Rasy
When p53 needs p73 to be functional - forced p73 expression induces nuclear accumulation of endogenous p53 protein.
Cancer letters 2003;197(1-2):99-103.
2003: Katherine K Matthay; Hervé Brisse; Dominique Couanet; Jérôme Couturier; Jean Bénard; Véronique Mosseri; Véronique Edeline; Jean Lumbroso; Dominique Valteau-Couanet; Jean Michon
Central nervous system metastases in neuroblastoma: radiologic, clinical, and biologic features in 23 patients.
Cancer 2003;98(1):155-65.
2003: Etienne Blanc; David Goldschneider; Eric Ferrandis; Michel Barrois; Gwenaëlle Le Roux; stephane leonce; Sétha Douc-Rasy; Jean Bénard; Gilda Raguénez
MYCN enhances P-gp/MDR1 gene expression in the human metastatic neuroblastoma IGR-N-91 model.
The American journal of pathology 2003;163(1):321-31.
2003: Stéphane Temam; Martine Trassard; G Leroux; Jacques Bosq; Bernard Luboinski; Gilbert Lenoir; Jean Bénard; François Janot
Cytology vs molecular analysis for the detection of head and neck squamous cell carcinoma in oesopharyngeal brush samples: a prospective study in 56 patients.
British journal of cancer 2003;88(11):1740-5.
2003: Sétha Douc-Rasy; Jean Bénard
[A new view on p53 protein cytoplasmic sequestration].
Bulletin du cancer 2003;90(5):380-2.
2003: Jean Bénard; Sétha Douc-Rasy; Jean-Charles Ahomadegbe
TP53 family members and human cancers.
Human mutation 2003;21(3):182-91.
2002: Jean Bénard; Jean-Charles Ahomadégbé
[p53 status and response to chemotherapy].
Bulletin du cancer 2002;89(12):1007-10.
2002: Alexander Valent; Gwenaëlle Le Roux; Michel Barrois; Marie-José Terrier-Lacombe; Dominique Valteau-Couanet; Bernadette Léon; Barbara Spengler; Gilbert Lenoir; Jean Bénard; Alain BERNHEIM
MYCN gene overrepresentation detected in primary neuroblastoma tumour cells without amplification.
The Journal of pathology 2002;198(4):495-501.
2002: Dominique Valteau-Couanet; Christophe Leboulaire; Kim Maincent; Muriel Tournier; Olivier Hartmann; Jean Bénard; Françoise Beaujean; Catherine Boccaccio; Laurence Zitvogel; Eric Angevin
Dendritic cells for NK/LAK activation: rationale for multicellular immunotherapy in neuroblastoma patients.
Blood 2002;100(7):2554-61.
2002: Muriel Vayssade; Laetitia Faridoni-Laurens; Jean Bénard; Jean-Charles Ahomadegbe
Expression of p53-family members and associated target molecules in breast cancer cell lines in response to vincristine treatment.
Biochemical pharmacology 2002;63(9):1609-17.
2002: Sétha Douc-Rasy; Michel Barrois; Maria Echeynne; Mourad Kaghad; Etienne Blanc; Gilda Raguenez; David Goldschneider; Marie-José Terrier-Lacombe; Olivier Hartmann; Ute M Moll; Daniel Caput; Jean Bénard
DeltaN-p73alpha accumulates in human neuroblastic tumors.
The American journal of pathology 2002;160(2):631-9.
2001: Laetitia Faridoni-Laurens; Jacques Bosq; François Janot; Muriel Vayssade; ML Le Bihan; Mourad Kaghad; Daniel Caput; Jean Bénard; Jean-Charles Ahomadegbe
P73 expression in basal layers of head and neck squamous epithelium: a role in differentiation and carcinogenesis in concert with p53 and p63?
Oncogene 2001;20(38):5302-12.
2001: G Riou; Marie-Christine Mathieu; Michel Barrois; ML Le Bihan; Jean-Charles Ahomadegbe; Jean Bénard; Monique G Lê
c-erbB-2 (HER-2/neu) gene amplification is a better indicator of poor prognosis than protein over-expression in operable breast-cancer patients.
International journal of cancer. Journal international du cancer 2001;95(4):266-70.
2001: Daniel Satgé; A J Sasco; Dominique Plantaz; Jean Bénard; M J Vekemans
Abnormal number of X chromosomes and neuroblastic tumors.
Journal of pediatric hematology/oncology 2001;23(5):331-2.
2001: Alexander Valent; Jean Bénard; Bernard Clausse; Michel Barrois; Dominique Valteau-Couanet; Marie-José Terrier-Lacombe; Barbara Spengler; Alain BERNHEIM
In vivo elimination of acentric double minutes containing amplified MYCN from neuroblastoma tumor cells through the formation of micronuclei.
The American journal of pathology 2001;158(5):1579-84.
2001: Gilda Raguénez; Sétha Douc-Rasy; Etienne Blanc; David Goldschneider; Michel Barrois; Dominique Valteau-Couanet; Jean Bénard
[A functional gene map is required to adapt therapy of metastatic neuroblastoma].
Bulletin du cancer 2001;88(3):295-304.
2001: D Plantaz; Jo Vandesompele; Nadine Van Roy; Maria Lastowska; Nick Bown; Valérie Combaret; M C Favrot; O Delattre; J Michon; Jean Bénard; O Hartmann; JC Nicholson; Fiona M Ross; Christian Brinkschmidt; Geneviève Laureys; H Caron; K K Matthay; Burt Feuerstein; Frank Speleman
Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11q deletion in tumors lacking MYCN amplification.
International journal of cancer. Journal international du cancer 2001;91(5):680-6.
2001: Michel Barrois; M K Eychenne; Marie-José Terrier-Lacombe; N Duarte; C Dubourg; Sétha Douc-Rasy; Agnès Chompret; M Khagad; Olivier Hartmann; Daniel Caput; Jean Bénard
Genomic and allelic expression status of the p73 gene in human neuroblastoma.
Medical and pediatric oncology 2001;36(1):45-7.
2001: Alexander Valent; AM Venuat; Gisèle Danglot; J Da Silva; N Duarte; Alain BERNHEIM; Jean Bénard
Stromal cells and human malignant neuroblasts derived from bone marrow metastasis may share common karyotypic abnormalities: the case of the IGR-N-91 cell line.
Medical and pediatric oncology 2001;36(1):100-3.
2000: Jean Bénard; Gilda Raguenez; Sétha Douc-Rasy
[Id2, a go-between in the Myc-Rb pair].
Bulletin du cancer 2000;87(12):877-80.
2000: Jean-Charles Ahomadegbe; Sophie Tourpin; Mourad Kaghad; Laurent Zelek; Muriel Vayssade; Marie-Christine Mathieu; France Rochard; Marc Spielmann; Thomas Tursz; Daniel Caput; G Riou; Jean Bénard
Loss of heterozygosity, allele silencing and decreased expression of p73 gene in breast cancers: prevalence of alterations in inflammatory breast cancers.
Oncogene 2000;19(47):5413-8.
2000: Barbara Dieumegard; Sophie Grandjouan; Jean-Christophe Sabourin; ML Le Bihan; I Lefrère; Jean-Pierre Pignon; Philippe Rougier; Philippe Lasser; Jean Bénard; Daniel Couturier; Brigitte Bressac De-Paillerets
Extensive molecular screening for hereditary non-polyposis colorectal cancer.
British journal of cancer 2000;82(4):871-80.
2000: Dominique Bellet; Vladimir Lazar; B B de Paillerets; Annelise Bennaceur-Griscelli; Jean Bénard; Jean-Michel Bidart
[Evolution of cancer markers: from radio-immunology to DNA chips and from surveillance to forecasting].
Bulletin du cancer 2000;87(1):35-9.
1999: Alexander Valent; Jean Bénard; Anne-Marie Vénuat; J Silva; A Duverger; N Duarte; Olivier Hartmann; Barbara Spengler; Alain BERNHEIM
Phenotypic and genotypic diversity of human neuroblastoma studied in three IGR cell line models derived from bone marrow metastases.
Cancer genetics and cytogenetics 1999;112(2):124-9.
1998: Philippe Jais; Jean-Christophe Sabourin; Johny Bombled; Philippe Rougier; Philippe Lasser; Pierre Duvillard; Jean Bénard; Brigitte Bressac De-Paillerets
Absence of somatic alterations of the EB1 gene adenomatous polyposis coli-associated protein in human sporadic colorectal cancers.
British journal of cancer 1998;78(10):1356-60.
1998: Valérie Combaret; O Delattre; Jean Bénard; Marie-Christine Favrot
[Biological markers for the prognosis of neuroblastoma: proposal of a method of analysis].
Bulletin du cancer 1998;85(3):262-6.
1998: Nadem Soufir; Marie-Françoise Avril; Agnès Chompret; Florence Demenais; Johny Bombled; Alain Spatz; Dominique Stoppa-Lyonnet; Jean Bénard; Brigitte Bressac De-Paillerets
Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group.
Human molecular genetics 1998;7(2):209-16.
1998: Jean Bénard; Brigitte Bressac De-Paillerets
[Update on genetic markers of cancer].
Bulletin du cancer 1998;85(1):21-6.
1997: Jean Bénard; J C Ahomadégbé
[TSG101 and breast cancer: a correctly named tumor-suppressor gene?].
Bulletin du cancer 1997;84(12):1141-2.
1997: Gilles Vassal; Corinne Pondarré; C Cappelli; Marie-José Terrier-Lacombe; I Boland; Jackie Morizet; Jean Bénard; Anne-Marie Vénuat; Patrice Ardouin; Olivier Hartmann; Alain Gouyette
DNA-topoisomerase I, a new target for the treatment of neuroblastoma.
European journal of cancer (Oxford, England : 1990) 1997;33(12):2011-5.
1997: Hervé Rubie; O Delattre; Olivier Hartmann; Valérie Combaret; Jean Michon; Jean Bénard; MC Peyroulet; Dominique Plantaz; Carole Coze; Pascal Chastagner; Marie-Christine Baranzelli; Didier Frappaz; Jean Lemerle; Danièle Sommelet
Loss of chromosome 1p may have a prognostic value in localised neuroblastoma: results of the French NBL 90 Study. Neuroblastoma Study Group of the Société Française d'Oncologie Pédiatrique (SFOP).
European journal of cancer (Oxford, England : 1990) 1997;33(12):1917-22.
1997: Hervé Rubie; Olivier Hartmann; Jean Michon; Didier Frappaz; Carole Coze; Pascal Chastagner; Marie-Christine Baranzelli; Dominique Plantaz; H Avet-Loiseau; Jean Bénard; O Delattre; M Favrot; MC Peyroulet; Antoine Thyss; Yves Perel; Christophe Bergeron; B Courbon-Collet; Jean-Pierre Vannier; Jean Lemerle; Danièle Sommelet
N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie Pédiatrique.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(3):1171-82.
1997: D Cappellen; Jean Bénard
Pleiotropic over-expression of multidrug-resistance-related genes is correlated to MYCN and max mRNA accumulation during tumour progression in the IGR-N-91 human neuroblastoma model.
International journal of cancer. Journal international du cancer 1997;70(4):430-6.
1996: Mounira Meddeb; Gisèle Danglot; I Chudoba; Anne-Marie Vénuat; Jean Bénard; H Avet-Loiseau; B Vasseur; D Le Paslier; Marie-José Terrier-Lacombe; Olivier Hartmann; Alain BERNHEIM
Additional copies of a 25 Mb chromosomal region originating from 17q23.1-17qter are present in 90% of high-grade neuroblastomas.
Genes, chromosomes & cancer 1996;17(3):156-65.
1996: Anne Fajac; J Da Silva; J C Ahomadegbe; J G Rateau; J F Bernaudin; G Riou; Jean Bénard
Cisplatin-induced apoptosis and p53 gene status in a cisplatin-resistant human ovarian carcinoma cell line.
International journal of cancer. Journal international du cancer 1996;68(1):67-74.
1996: Gilles Vassal; Marie-José Terrier-Lacombe; MC Bissery; Anne-Marie Vénuat; F Gyergyay; Jean Bénard; Jackie Morizet; I Boland; Patrice Ardouin; Brigitte Bressac De-Paillerets; Alain Gouyette
Therapeutic activity of CPT-11, a DNA-topoisomerase I inhibitor, against peripheral primitive neuroectodermal tumour and neuroblastoma xenografts.
British journal of cancer 1996;74(4):537-45.
1995: C Muller; F Goubin; E Ferrandis; I Cornil-Scharwtz; J D Bailly; C Bordier; Jean Bénard; Branimir I Sikic; Guy Laurent
Evidence for transcriptional control of human mdr1 gene expression by verapamil in multidrug-resistant leukemic cells.
Molecular pharmacology 1995;47(1):51-6.
1995: Jean Bénard
Genetic alterations associated with metastatic dissemination and chemoresistance in neuroblastoma.
European journal of cancer (Oxford, England : 1990) 1995;31A(4):560-4.
1994: T Voeltzel; Pierre Duvillard; P Ghillani; Jean Bénard; C Bohuon; Dominique Bellet; Jean-Michel Bidart
Distribution of VRA09, an ovarian tumor-associated antigen, distinguishing borderline serous tumors.
International journal of cancer. Journal international du cancer 1994;59(2):159-64.
1994: Jean Bénard; J Bourhis; Florent de Vathaire; E Ferrandis; Marie-José Terrier-Lacombe; Jean Lemerle; G Riou; Olivier Hartmann
Prognostic value of MDR1 gene expression in neuroblastoma: results of a multivariate analysis.
Progress in clinical and biological research 1994;385():111-6.
1994: E Ferrandis; Jean Bénard
Retinoic acid and forskolin activate the human MDR1 gene promoter in differentiated neuroblasts.
Progress in clinical and biological research 1994;385():103-10.
1993: E Ferrandis; Jean Bénard
Activation of the human MDR1 gene promoter in differentiated neuroblasts.
International journal of cancer. Journal international du cancer 1993;54(6):987-91.
1992: J R Teyssier; P Couillin; Jean Bénard; N Ravisse; E Ulrich; P Cornillet
A multidrug-resistant ovarian carcinoma cell line with a malignant suppressed phenotype is a CD44 gene expression defective mutant.
Cancer genetics and cytogenetics 1992;60(1):14-9.
1991: T Voeltzel; Jean Bénard; L Lavaissiere; P Solère; J Da Silva; C Bohuon; Jean-Michel Bidart
Antigenic properties associated with Vinca alkaloid resistance in ovarian cancer cells: identification of a 92,000 Da protein.
Biochemical and biophysical research communications 1991;180(1):334-41.
1991: J Bourhis; C Dominici; H McDowell; G Raschella; G Wilson; Manuel A Castello; E Plouvier; Jean Lemerle; G Riou; Jean Bénard
N-myc genomic content and DNA ploidy in stage IVS neuroblastoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(8):1371-5.
1991: J Bourhis; Olivier Hartmann; F DeVathaire; Marie-José Terrier-Lacombe; L Boccon-Gibod; Jean Lemerle; G Riou; Jean Bénard
Expression of MDR1 and GST pi genes in 35 advanced neuroblastomas.
Progress in clinical and biological research 1991;366():127-34.
1991: J Bourhis; Jean Bénard; F DeVathaire; George D Wilson; Olivier Hartmann; Marie-José Terrier-Lacombe; L Boccon-Gibod; Jean Lemerle; G Riou
Combined analysis of DNA ploidy index and N-myc genomic content in neuroblastoma.
Progress in clinical and biological research 1991;366():107-13.
1991: Jean Bénard; J Bourhis; G Riou
[Activation of N-myc oncogene and associated genes to chemoresistance, prognostic value for neuroblastoma].
Bulletin du cancer 1991;78(1):91-7.
1991: J Bourhis; Florent de Vathaire; George D Wilson; Olivier Hartmann; Marie-José Terrier-Lacombe; L Boccon-Gibod; N J McNally; Jean Lemerle; G Riou; Jean Bénard
Combined analysis of DNA ploidy index and N-myc genomic content in neuroblastoma.
Cancer research 1991;51(1):33-6.
1990: Jean Bénard; J Bourhis; G Riou
Clinical significance of multiple drug resistance in human cancers.
Anticancer research 1990;10(5A):1297-302.
1990: J Bourhis; G Riou; Jean Bénard
[Expression of P-glycoprotein 170 (GP 170) and drug resistance in human cancers].
Bulletin du cancer 1990;77(10):957-65.
1989: L Bettan-Renaud; Florent de Vathaire; Jean Bénard; N Morardet; N Pauzie; S Bayet; Olivier Hartmann; Claude Parmentier
Potential therapeutic role of cisplatinum in autologous bone marrow transplantation: in vitro eradication of neuroblastoma cells from bone marrow.
British journal of cancer 1989;60(4):529-32.
1989: J Bourhis; Jean Bénard; O Hartmann; L Boccon-Gibod; J Lemerle; G Riou
Correlation of MDR1 gene expression with chemotherapy in neuroblastoma.
Journal of the National Cancer Institute 1989;81(18):1401-5.
1989: J Bourhis; L J Goldstein; G Riou; Ira Pastan; Michael M Gottesman; Jean Bénard
Expression of a human multidrug resistance gene in ovarian carcinomas.
Cancer research 1989;49(18):5062-5.
1989: J R Teyssier; Jean Bénard; D Ferre; J Da Silva; L Renaud
Drug-related chromosomal changes in chemoresistant human ovarian carcinoma cells.
Cancer genetics and cytogenetics 1989;39(1):35-43.
1989: Jean Bénard; J Da Silva; J R Teyssier; G Riou
Over-expression of MDR1 gene with no DNA amplification in a multiple-drug-resistant human ovarian carcinoma cell line.
International journal of cancer. Journal international du cancer 1989;43(3):471-7.
1985: Jean Bénard; J Da Silva; M C De Blois; pierre boyer; P Duvillard; E Chiric; G Riou
Characterization of a human ovarian adenocarcinoma line, IGROV1, in tissue culture and in nude mice.
Cancer research 1985;45(10):4970-9.